Literature DB >> 12675128

Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.

Frank P Bymaster1, David L McKinzie, Christian C Felder, Jürgen Wess.   

Abstract

In this review we report recent findings on the physiological role of the five known muscarinic acetylcholine receptors (mAChRs) as shown by gene targeting technology. Using knockout mice for each mAChRs subtype, the role of mAChRs subtypes in a number of physiological functions was confirmed and new activities were discovered. The M1 mAChRs modulate neurotransmitter signaling in cortex and hippocampus. The M3 mAChRs are involved in exocrine gland secretion, smooth muscle contractility, pupil dilation, food intake, and weight gain. The role of the M5 mAChRs involves modulation of central dopamine function and the tone of cerebral blood vessels. mAChRs of the M2 subtype mediate muscarinic agonist-induced bradycardia, tremor, hypothermia, and autoinhibition of release in several brain regions. M4 mAChRs modulate dopamine activity in motor tracts and act as inhibitory autoreceptors in striatum. Thus, as elucidated by gene targeting technology, mAChRs have widespread and manifold functions in the periphery and brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675128     DOI: 10.1023/a:1022844517200

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

Review 1.  Muscarinic receptor ligands and their therapeutic potential.

Authors:  R M Eglen; A Choppin; M P Dillon; S Hegde
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

2.  Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.

Authors:  Weilie Zhang; Anthony S Basile; Jesus Gomeza; Laura A Volpicelli; Allan I Levey; Jürgen Wess
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

3.  Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.

Authors:  S K Hemrick-Luecke; F P Bymaster; D C Evans; J Wess; C C Felder
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

4.  An unusual type of sympathetic ganglionic stimulant.

Authors:  A P ROSZKOWSKI
Journal:  J Pharmacol Exp Ther       Date:  1961-05       Impact factor: 4.030

5.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  D J Gerber; T D Sotnikova; R R Gainetdinov; S Y Huang; M G Caron; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 7.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

8.  Muscarinic acetylcholine receptor subtypes in the human iris.

Authors:  N Ishizaka; M Noda; S Yokoyama; K Kawasaki; M Yamamoto; H Higashida
Journal:  Brain Res       Date:  1998-03-23       Impact factor: 3.252

9.  M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices.

Authors:  J L Berkeley; J Gomeza; J Wess; S E Hamilton; N M Nathanson; A I Levey
Journal:  Mol Cell Neurosci       Date:  2001-11       Impact factor: 4.314

10.  Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity.

Authors:  Frank P Bymaster; Petra A Carter; Masahisa Yamada; Jesus Gomeza; Jürgen Wess; Susan E Hamilton; Neil M Nathanson; David L McKinzie; Christian C Felder
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

View more
  62 in total

Review 1.  Muscarinic receptors: what we know.

Authors:  Harriette M Scarpero; Roger R Dmochowski
Journal:  Curr Urol Rep       Date:  2003-12       Impact factor: 3.092

Review 2.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Discovery of potential antipsychotic agents possessing pro-cognitive properties.

Authors:  Jelveh Lameh; Krista McFarland; Jorgen Ohlsson; Fredrik Ek; Fabrice Piu; Ethan S Burstein; Ali Tabatabaei; Roger Olsson; Stefania Risso Bradley; Douglas W Bonhaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-15       Impact factor: 3.000

Review 4.  The antipsychotic potential of muscarinic allosteric modulation.

Authors:  Thomas M Bridges; Evan P LeBois; Corey R Hopkins; Michael R Wood; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley
Journal:  Drug News Perspect       Date:  2010-05

Review 5.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

6.  Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.

Authors:  L Michelle Lewis; Douglas Sheffler; Richard Williams; Thomas M Bridges; J Phillip Kennedy; J T Brogan; Matthew J Mulder; Lyndsey Williams; Natalia T Nalywajko; Colleen M Niswender; Charles D Weaver; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-01-04       Impact factor: 2.823

7.  Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.

Authors:  Thomas M Bridges; Ashley E Brady; J Phillip Kennedy; R Nathan Daniels; Nicole R Miller; Kwango Kim; Micah L Breininger; Patrick R Gentry; John T Brogan; Carrie K Jones; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-09-10       Impact factor: 2.823

8.  Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists.

Authors:  Nicole R Miller; R Nathan Daniels; David Lee; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2010-02-13       Impact factor: 2.823

9.  Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Authors:  Anders Fink-Jensen; Lene S Schmidt; Ditte Dencker; Christina Schülein; Jürgen Wess; Gitta Wörtwein; David P D Woldbye
Journal:  Eur J Pharmacol       Date:  2011-01-24       Impact factor: 4.432

10.  Synthesis and SAR of analogs of the M1 allosteric agonist TBPB. Part II: Amides, sulfonamides and ureas--the effect of capping the distal basic piperidine nitrogen.

Authors:  Nicole R Miller; R Nathan Daniels; Thomas M Bridges; Ashley E Brady; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2008-09-11       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.